Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jenny Harry Insider Profile
4 Followers
Jenny Harry, Director at Neuren Pharmaceuticals Limited, holds 29.66K shares in Neuren Pharmaceuticals Limited (Ticker: NURPF), holds 11.06M shares in Contango Asset Management Ltd. (Ticker: AU:APL). Most recently, Jenny Harry Bought ― shares of Neuren Pharmaceuticals Limited on Oct 08, 2021 for an estimated value of 20.00K.
Jenny Harry Neuren Pharmaceuticals Limited (NURPF)Director
Neuren Pharmaceuticals Limited (NURPF)
Director
Ranked #15,416 out of 97,944 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
+56.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jenny Harry holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Oct 08, 2021 - Oct 08, 2022
Return:+197.60%
The most profitable trade made by Jenny Harry
Jenny Harry's Trading History
Neuren Pharmaceuticals Limited
Oct 08, 2021
Director
Informative Buy
20.00K
$422.70K
Contango Asset Management Ltd.
Feb 18, 2011
Senior Officer
Uninformative Sell
―
AU$1.49M
List of latest transactions for each holding click on a transaction to see Jenny Harry's performance on stock
You May Also Like
Jenny Harry insider profile FAQ
What is the percentage of profitable transactions made by Jenny Harry?
The percentage of profitable transactions made by Jenny Harry is 33%.
What is the average return per transaction made by Jenny Harry?
The average return per transaction made by Jenny Harry is 56.90%.
What stocks does Jenny Harry hold?
Jenny Harry holds: NURPF, AU:APL stocks.
What was Jenny Harry’s latest transaction?
Jenny Harry latest transaction was an Informative Buy of $20.00K.
What was Jenny Harry's most profitable transaction?
Jenny Harry’s most profitable transaction was an Informative Buy of NURPF stock on October 8, 2021. The return on the trade was 197.60%.
What is Jenny Harry's role in Neuren Pharmaceuticals Limited?
Jenny Harry's role in Neuren Pharmaceuticals Limited is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.